Pulse Biosciences, Inc. (Nasdaq:plse)Q1 2025 Revenue Call May 8, 2025 at 4:30pm
Company participants
Philip Taylor – Gilmalting Loop
John Skinner – CFO
Paul Laviolette – CEO and co-chair of the Board
Participants in conference calls
operator
Hello, women and gentlemen and welcome to the 2025 financial results conference call for the first quarter of Pulse Biosciences. At this point, all rows are in listening only mode. A Q&A session will be held following the presentation. [Operator Instructions]. This call was recorded on Thursday, May 8, 2025. I would like to hand over the meeting to today’s first speaker, Trip Taylor, Investor Relations. Please move on.
Philip Taylor
Thank you, operator. Before we begin, we would like to inform you that any comments and answers to your questions during today’s call reflect the views of management on May 8, 2025 only and include forward-looking statements and opinions, including forecasts, estimates, plans, expectations and other similar information. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully explained in a press release issued earlier today and in a filing with the Securities and Exchange Commission.
Our SEC filings can be found on our website or the SEC website. Investors are careful not to overreliate on forward-looking statements. We waive any obligation to update or modify these forward-looking statements. We will also discuss certain non-GAAP financial indicators. Disclosures regarding these non-GAAP financial measures, including readjustment with the most comparable GAAP measures, can be found in the press release. This conference call will make audio replays available in the News and Events section of the Investor Relations page on our website PulseBiosciences.com. So, I would like to hand over the call to the co-chair now.
